Daily single-dose gentamicin therapy in experimental pyelonephritis.

Area of Science:

• Pharmacology
• Nephrology
• Infectious Diseases

Background:

• Gentamicin is a critical antibiotic for treating bacterial infections.
• Optimizing gentamicin dosing regimens is essential for maximizing therapeutic efficacy and minimizing toxicity.
• Renal infections require careful consideration of antibiotic delivery to ensure adequate drug concentration at the site of infection.

Purpose of the Study:

• To compare the therapeutic efficacy of once-daily versus thrice-daily gentamicin administration.
• To evaluate the impact of dosing frequency on gentamicin's effectiveness in experimental renal infections in rats.
• To determine if the duration of therapy influences the optimal gentamicin dosing strategy.

Main Methods:

• An experimental model of renal infection was established in rats.
• Gentamicin was administered either once daily or three times daily at equivalent total daily doses.
• Bacterial counts in the kidney were assessed after five and ten days of treatment.
• A separate comparison involved a single daily dose (two-thirds of the total thrice-daily dose) versus thrice-daily injections.

Main Results:

• For incipient renal infections, no statistically significant difference in efficacy was observed between once-daily and thrice-daily gentamicin administration.
• In advanced infections, the difference in efficacy between once-daily and thrice-daily dosing became apparent after ten days, with thrice-daily administration being more effective.
• A single daily dose of gentamicin, amounting to two-thirds of the total thrice-daily dose, resulted in significantly lower kidney bacterial counts than thrice-daily injections after five days.

Conclusions:

• Dosing frequency of gentamicin does not significantly impact treatment outcomes for early-stage renal infections.
• For advanced renal infections, a thrice-daily gentamicin dosing regimen is more effective than once-daily administration, particularly after prolonged treatment (ten days).
• Further research may be warranted to explore optimal gentamicin dosing strategies, considering dose reduction and frequency for specific infection stages.